P2Y12 Platelet Inhibitor [EPC]

23563 reported adverse events

Drugs of this class: TICAGRELOR CANGRELOR

These side effects are most commonly reported by patients taking drugs of the P2Y12 Platelet Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 3222
1 MYOCARDIAL INFARCTION 2088
2 OFF LABEL USE 1326
3 CHEST PAIN 1227
4 FATIGUE 1213
5 DEATH 1100
6 DIZZINESS 974
7 CONTUSION 931
8 MALAISE 769
9 HAEMORRHAGE 749
See all common reactions for P2Y12 Platelet Inhibitor [EPC]

Drugs of the P2Y12 Platelet Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR STENT OCCLUSION 145 0.4739
1 DIABETIC MACROANGIOPATHY 12 0.4138
2 VASCULAR STENT THROMBOSIS 609 0.3833
3 VASCULAR STENT RESTENOSIS 28 0.2979
4 VASCULAR STENT STENOSIS 68 0.2720
5 ARTERIAL RESTENOSIS 19 0.1624
6 PLATELET AGGREGATION INHIBITION 10 0.1351
7 VENTRICULAR ASYSTOLE 18 0.1277
8 THROMBOSIS IN DEVICE 335 0.1091
9 STENT MALFUNCTION 18 0.1084
See all enriched reactions for P2Y12 Platelet Inhibitor [EPC]